🇺🇸 FDA
Patent

US 9186413

Sustained delivery formulations of risperidone compounds

granted A61KA61K31/519A61K47/22

Quick answer

US patent 9186413 (Sustained delivery formulations of risperidone compounds) held by Indivior UK Limited expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Indivior UK Limited
Grant date
Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/519, A61K47/22, A61K47/32, A61K47/34